Status:

COMPLETED

Obesity and Intracytoplasmic Sperm Injection Cycle Outcome

Lead Sponsor:

Assiut University

Conditions:

Infertility

Eligibility:

FEMALE

18-35 years

Phase:

NA

Brief Summary

Obesity has been associated with menstrual irregularities, chronic an-ovulation, infertility, and poor outcomes in women undergoing in vitro fertilization. There is strong evidence that obesity is as...

Eligibility Criteria

Inclusion

  • Age of women 18 - 35 yrs old.
  • Women with Body mass index I 18 - 35 kg/m2.
  • Infertile women with an indication for In vitro fertilization
  • Anticipated normal responders.
  • Normal uterine cavity by trans-vaginal ultrasound.

Exclusion

  • Poly cystic ovarian syndrome
  • Diabetic patients.
  • Known Poor ovarian response
  • Patients with abnormal uterine cavity.
  • Refusal to participate in the study.

Key Trial Info

Start Date :

February 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 26 2022

Estimated Enrollment :

88 Patients enrolled

Trial Details

Trial ID

NCT03778684

Start Date

February 1 2019

End Date

November 26 2022

Last Update

November 30 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Women Health Hospital - Assiut university

Asyut, Egypt, 71111

Obesity and Intracytoplasmic Sperm Injection Cycle Outcome | DecenTrialz